Key Positions of HIV-1 Env and Signatures of Vaccine Efficacy Show Gradual Reduction of Population Founder Effects at the Clade and Regional Levels
ABSTRACT HIV-1 group M was transmitted to humans nearly one century ago. The virus has since evolved to form distinct clades, which spread to different regions of the world. The envelope glycoproteins (Envs) of HIV-1 have rapidly diversified in all infected populations. We examined whether key antig...
Main Authors: | Changze Han, Jacklyn Johnson, Rentian Dong, Raghavendranath Kandula, Alexa Kort, Maria Wong, Tianbao Yang, Patrick J. Breheny, Grant D. Brown, Hillel Haim |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2020-06-01
|
Series: | mBio |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/mBio.00126-20 |
Similar Items
-
SERINC5 Restricts HIV-1 Infectivity by Promoting Conformational Changes and Accelerating Functional Inactivation of Env
by: Junghwa Kirschman, et al.
Published: (2022-06-01) -
Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators
by: Shiyu Zhang, et al.
Published: (2021-10-01) -
Immunization with HIV-1 trimeric SOSIP.664 BG505 or founder virus C (FVCEnv) covalently complexed to two-domain CD4S60C elicits cross-clade neutralizing antibodies in New Zealand white rabbits
by: Nancy L. Tumba, et al.
Published: (2022-12-01) -
The Past, Present, and Future of a Human T-Cell Leukemia Virus Type 1 Vaccine
by: Joshua J. Tu, et al.
Published: (2022-05-01) -
The Characteristics of the HIV-1 Env Glycoprotein Are Linked With Viral Pathogenesis
by: Silvia Pérez-Yanes, et al.
Published: (2022-03-01)